Aranda Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $790K

  • Investors
  • 3

Aranda Pharma General Information

Description

Developer of novel antiandrogen drugs intended to combat prostate cancer and neurodegenerative diseases. The company's drugs are made of small molecules and androgen receptor antagonists that are non-toxic, and provide effective treatments for hair loss and acne, which are underrepresented drug targets despite being validated without affecting hormonal function in other parts of the body, enabling clients to improve the quality of life for millions of people suffering from hair loss and acne.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Haartmaninkatu 4
  • Terkko Health Hub, Building 14
  • 00290 Helsinki
  • Finland
+358 044
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Haartmaninkatu 4
  • Terkko Health Hub, Building 14
  • 00290 Helsinki
  • Finland
+358 044

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aranda Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Equity Crowdfunding 30-Dec-2021 $790K Completed Pre-Clinical Trials
2. Early Stage VC 21-May-2018 Completed Startup
1. Seed Round 04-Nov-2015 Completed Startup
To view Aranda Pharma’s complete valuation and funding history, request access »

Aranda Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
To view Aranda Pharma’s complete cap table history, request access »

Aranda Pharma Patents

Aranda Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9827249-B2 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Active 31-May-2013
ES-2715877-T3 Use of fused benzo [b] thiazine derivatives as cytoprotectors Active 31-May-2013
US-20160106754-A1 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Active 31-May-2013
EP-3004118-A1 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Active 31-May-2013
EP-3004118-B1 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Active 31-May-2013 A61K31/542
To view Aranda Pharma’s complete patent history, request access »

Aranda Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aranda Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovestor Venture Capital Minority
Finnvera Lender/Debt Provider Minority
Tarrex Biopharma Corporation Minority
To view Aranda Pharma’s complete investors history, request access »

Aranda Pharma FAQs

  • When was Aranda Pharma founded?

    Aranda Pharma was founded in 2015.

  • Where is Aranda Pharma headquartered?

    Aranda Pharma is headquartered in Helsinki, Finland.

  • What is the size of Aranda Pharma?

    Aranda Pharma has 5 total employees.

  • What industry is Aranda Pharma in?

    Aranda Pharma’s primary industry is Drug Discovery.

  • Is Aranda Pharma a private or public company?

    Aranda Pharma is a Private company.

  • What is Aranda Pharma’s current revenue?

    The current revenue for Aranda Pharma is .

  • How much funding has Aranda Pharma raised over time?

    Aranda Pharma has raised $2.42M.

  • Who are Aranda Pharma’s investors?

    Innovestor, Finnvera, and Tarrex Biopharma have invested in Aranda Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »